Literature DB >> 24927056

Evaluation of the antiprion activity of 6-aminophenanthridines and related heterocycles.

Phuhai Nguyen1, Nassima Oumata2, Flavie Soubigou1, Justine Evrard1, Nathalie Desban3, Pascale Lemoine4, Serge Bouaziz4, Marc Blondel1, Cécile Voisset1.   

Abstract

Series of 6-aminophenanthridines and related heterocyclic compounds such as benzonaphtyridines were prepared. Reduction of one of the three aromatic rings was also performed. The compounds were first tested for their antiprion activity in a previously described yeast-based colourimetric prion assay. The most potent derivatives were then assayed ex vivo against the mammalian prion PrP(Sc) in a cell-based assay. Several of the new compounds were found more potent than the parent lead 6-aminophenanthridine. The most promising compounds against yeast and mammalian prions were 8-azido-6-aminophenanthridine (3m), and 7,10-dihydrophenanthridin-6-amine (14). In the mammalian cell-based assay, the IC50 of these two compounds were around 5 μM and 1.8 μM, respectively.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Neurodegenerative diseases; Phenanthridine; Prions; Protein misfolding

Mesh:

Substances:

Year:  2014        PMID: 24927056     DOI: 10.1016/j.ejmech.2014.05.083

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  5 in total

Review 1.  Yeast prions: structure, biology, and prion-handling systems.

Authors:  Reed B Wickner; Frank P Shewmaker; David A Bateman; Herman K Edskes; Anton Gorkovskiy; Yaron Dayani; Evgeny E Bezsonov
Journal:  Microbiol Mol Biol Rev       Date:  2015-03       Impact factor: 11.056

Review 2.  Application of yeast to studying amyloid and prion diseases.

Authors:  Yury O Chernoff; Anastasia V Grizel; Aleksandr A Rubel; Andrew A Zelinsky; Pavithra Chandramowlishwaran; Tatiana A Chernova
Journal:  Adv Genet       Date:  2020-05-04       Impact factor: 1.944

Review 3.  Proteinopathies: Deciphering Physiology and Mechanisms to Develop Effective Therapies for Neurodegenerative Diseases.

Authors:  Gouri Chopra; Shabnam Shabir; Sumaira Yousuf; Simran Kauts; Shahnawaz A Bhat; Ashiq H Mir; Mahendra P Singh
Journal:  Mol Neurobiol       Date:  2022-10-07       Impact factor: 5.682

4.  Tuning the Photophysical Properties of Homoleptic Tris-Cyclometalated Ir(III) Complexes by Facile Modification of the Imidazo-Phenanthridine and Their Application to Phosphorescent Organic Light-Emitting Diodes.

Authors:  So-Yoen Kim; Jin-Hyoung Kim; Sanghun Lee; Bo-Sun Yun; Ho-Jin Son; Sang Ook Kang
Journal:  ACS Omega       Date:  2022-05-10

5.  Anti-prion Drugs Targeting the Protein Folding Activity of the Ribosome Reduce PABPN1 Aggregation.

Authors:  Aline Bamia; Maha Sinane; Rima Naït-Saïdi; Jamila Dhiab; Frédéric Bihel; Cécile Voisset; Marc Keruzoré; Phu Hai Nguyen; Agathe Bertho; Flavie Soubigou; Sophie Halliez; Marc Blondel; Capucine Trollet; Martine Simonelig; Gaëlle Friocourt; Vincent Béringue
Journal:  Neurotherapeutics       Date:  2021-02-02       Impact factor: 7.620

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.